Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    P2.06 - Pathology - Tumour Diagnostics

    • 17:15 - 19:15
    • 8/08/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Pathology - Tumour Diagnostics
    • +

      P2.06-01 - Skip Hilar Lymph Node Metastasis in Non-Small Cell Lung Cancer Has Similar Survival to N0 Disease: Need for a change in the pN sub-classification?

      Presenter: Ismail Sarbay

      • Abstract

      Loading...

  • +

    P2.07 - Pathology - Tumour Genomics

    • 17:15 - 19:15
    • 8/08/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Pathology - Tumour Genomics
    • +

      P2.07-01 - Deep-Learning Based Prediction of c-MET Status from Digitized H&E-Stained Non-Small Cell Lung Cancer Tissue Samples

      Presenter: Bahar Rahsepar

      • Abstract

      Loading...

    • +

      P2.07-02 - RET Fusion Testing with FISH and Real-Time PCR: a Comparison with RNA-Based Next-Generation Sequencing in RET Positive NSCLC

      Presenter: Susana Hernandez

      • Abstract

      Loading...

  • +

    P2.08 - Patient Advocacy

    • 17:15 - 19:15
    • 8/08/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Patient Advocacy
    • +

      P2.08-01 - Real-world barriers to clinical trial enrollment as reported by U.S. lung cancer patients and community cancer centers

      Presenter: Andrew Ciupek

      • Abstract

      Loading...

    • +

      P2.08-02 - Burning the Candle at Both Ends-Sleep Quality Before and After Chemotherapy in Lung Cancer Patients - A Systematic Review and Meta-Analysis

      Presenter: Andrew Thomas Jeklin

      • Abstract

      Loading...

    • +

      P2.08-03 - Patient Reported Lung Cancer Care Team Satisfaction and Treatment Dynamics, Based on the Online MyHealthTeams Survey

      Presenter: Dianna Cronin

      • Abstract

      Loading...

    • +

      P2.08-04 - Patient Reported Impact of Lung Cancer Symptoms and Treatment on Mental Health and Quality of Life, Based on the Online MyHealthTeams Survey

      Presenter: Dianna Cronin

      • Abstract

      Loading...

    • +

      P2.08-05 - Lung Cancer Patients’ Willingness to Attend a Screening Appointment or Lung Health Check: Insights from a Global Patient Experience Survey

      Presenter: Jackie Fenemore

      • Abstract

      Loading...

    • +

      P2.08-06 - Patient Involvement in Decision-Making around Their Treatment and Care: Findings from a Global Patient Experience Survey

      Presenter: Jackie Fenemore

      • Abstract

      Loading...

    • +

      P2.08-07 - The Campaign to End Lung Cancer Stigma: The ACS National Lung Cancer Roundtable Efforts to Confront and Extinguish Lung Cancer Stigma

      Presenter: Dusty Donaldson

      • Abstract

      Loading...

    • +

      P2.08-08 - Where Have All the Lung Cancer Support Groups Gone?

      Presenter: Maureen Rigney

      • Abstract

      Loading...

    • +

      P2.08-09 - Adaptation of Empathic Communication Skills Training for Oncology Care Providers to Reduce Lung Cancer Stigma

      Presenter: Jamie Ostroff

      • Abstract

      Loading...

  • +

    P2.09 - Pulmonology, Radiology, and Staging

    • 17:15 - 19:15
    • 8/08/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Pulmonology, Radiology, and Staging
    • +

      P2.09-01 - MRI-based Radiomic Signature to Predict Pathologic High-grade Pattern in Lung Adenocarcinoma

      Presenter: Harim Kim

      • Abstract

      Loading...

    • +

      P2.09-02 - Clinical Nodal (cN) Category Is Independently Prognostic for Overall Survival in Unresectable Advanced/Metastatic Lung Cancer

      Presenter: Navneet Singh

      • Abstract

      Loading...

    • +

      P2.09-03 - A Radiomics Approach Using Baseline CT Can Predict Response to 1st-Line Pembrolizumab in Advanced NSCLC with High PD-L1

      Presenter: Ren Yuan

      • Abstract

      Loading...

  • +

    P2.10 - Small Cell Lung Cancer and Neuro-endocrine Tumors

    • 17:15 - 19:15
    • 8/08/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Small Cell Lung Cancer and Neuro-endocrine Tumors
    • +

      P2.10-01 - Transcriptional Diversity of Emerging Cell Populations in Refractory Small Cell Lung Cancer Biopsies and Xenografts

      Presenter: Allison Stewart

      • Abstract

      Loading...

    • +

      P2.10-02 - EMERGE 402: Preliminary Real-world Characteristics and Safety of Lurbinectedin in Patients With Small-cell Lung Cancer

      Presenter: Balazs Halmos

      • Abstract

      Loading...

    • +

      P2.10-03 - High-dose Thoracic Radiotherapy Improves the Overall Survival of Oligo-Metastatic Extensive-Stage Small Cell Lung Cancer

      Presenter: Zhengfei Zhu

      • Abstract

      Loading...

    • +

      P2.10-04 - Immunologic Subtype of Small Cell Lung Carcinoma Dictates Susceptibility to NK Cell-Mediated Cytotoxicity

      Presenter: Navin R Mahadevan

      • Abstract

      Loading...

    • +

      P2.10-05 - Circulating CD3+CD56+ Cells as a Biomarker for Immunotherapy in SCLC.

      Presenter: vito longo

      • Abstract

      No abstract available for this presentation

  • +

    P2.11 - Tobacco Control and Risk Reduction

    • 17:15 - 19:15
    • 8/08/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Tobacco Control and Risk Reduction
    • +

      P2.11-01 - Awareness of Lung Cancer Risk Factors in Palestine: Current Situation and Future Directions

      Presenter: Ahmad Mansour

      • Abstract

      Loading...

    • +

      P2.11-02 - New Assay for Smoking Status based on 3D Imaging of Pulmonary Macrophages

      Presenter: Michael G Meyer

      • Abstract

      Loading...

    • +

      P2.11-03 - Smoking Prevention Intervention With School Classes in University Hospital by Thoracic Surgeon und Pulmonologist

      Presenter: Sven Hillinger

      • Abstract

      Loading...

  • +

    P2.12 - Tumor Biology and Biomarkers - Immune Biology & Immunotherapy

    • 17:15 - 19:15
    • 8/08/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Tumor Biology and Biomarkers - Immune Biology & Immunotherapy
    • +

      P2.12-01 - Intratumoral Conventional Type 1 Dendritic Cells (cDC1s) Predict Response to Immunotherapy in Human Non-small Cell Lung Cancer cancer (NSCLC)

      Presenter: Angelo Porciuncula

      • Abstract

      Loading...

    • +

      P2.12-02 - Immune-Cell Distribution Between Tumor Edge and Center Affects Lung Cancer Aggressiveness - Multiplex Immunofluorescence

      Presenter: Takashi Eguchi

      • Abstract

      Loading...

    • +

      P2.12-03 - External Validation of a Novel CT-Based Prognostic Radiomic Signature in Patients With Metastatic NSCLC in SWOG S0819 Phase III Randomized Trial

      Presenter: Laurent Dercle

      • Abstract

      Loading...

    • +

      P2.12-04 - The Role of Serum Proteomic Signature in Predicting Survival in PD-L1 Low Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitor (ICI)

      Presenter: YOUJIN OH

      • Abstract

      Loading...

    • +

      P2.12-05 - Cancer and Atopy: Parallel Drivers? IL-4 Blockade Synergizes with PD-L1 Blockade to Reverse Type-2Mediated Immunosuppression

      Presenter: Thomas Urban Marron

      • Abstract

      Loading...

  • +

    P2.13 - Tumor Biology and Biomarkers - Minimally Invasive Biomarkers

    • 17:15 - 19:15
    • 8/08/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Tumor Biology and Biomarkers - Minimally Invasive Biomarkers
    • +

      P2.13-01 - Low EV miR-30c Levels as Biomarker of Increased Tumor Autophagy and Chemoradiotherapy Resistance in Locally Advanced NSCLC

      Presenter: Diego de Miguel Perez

      • Abstract

      Loading...

    • +

      P2.13-02 - Dynamic Tracking of Bespoke Circulating Tumour DNA During Multi-Modality Therapy for Locally Advanced NSCLC (LA-NSCLC)

      Presenter: Kevin Lee Min Chua

      • Abstract

      Loading...

    • +

      P2.13-03 - Plasma Profiling Unveils Transcriptional Signatures Associated with Resistance to Osimertinib in Non-Small Cell Lung Cancer

      Presenter: Per Hydbring

      • Abstract

      Loading...

  • +

    P2.14 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics

    • 17:15 - 19:15
    • 8/08/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
    • +

      P2.14-01 - Clinical Utility of Reflex to Tissue-based Comprehensive Genomic Profiling (CGP) After Negative Liquid Biopsy (LBx) in NSCLC

      Presenter: Khaled Tolba

      • Abstract

      Loading...

    • +

      P2.14-02 - TP53 Mutations Affect Sensitivity to Lorlatinib in ROS1 Positive NSCLC: Final Results of the PFROST Trial

      Presenter: Lorenza Landi

      • Abstract

      Loading...

    • +

      P2.14-03 - Restored Ubiquitination and Degradation of Exon 14 Skipped MET with Proteolysis Targeting Chimeras

      Presenter: Aaron Scott Mansfield

      • Abstract

      Loading...

    • +

      P2.14-04 - Re-Definition of Lung Adenocarcinoma Transcriptional Subtypes Using Integrative Bioinformatics Approaches

      Presenter: Sara Hijazo-Pechero

      • Abstract

      Loading...

  • +

    P2.15 - Tumor Biology and Biomarkers - Tumour Biology & Preclinical Studies

    • 17:15 - 19:15
    • 8/08/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Tumor Biology and Biomarkers - Tumour Biology & Preclinical Studies
    • +

      P2.15-01 - Digital Pathology Uncovers Multi-Omic Hallmarks of Lung Cancer in Histopathology Images

      Presenter: Maria Guramare

      • Abstract

      Loading...